Author Guidelines

Author Guidelines

SUBMISSION OF MANUSCRIPTS

Authors should kindly note that manuscript submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.

Once the manuscript submission materials have been prepared in accordance with the Author Guidelines, manuscripts should be submitted online at : http://jorr.info/index.php/jorr/about/submissions  

The submission system will prompt the submitting author to use an ORCID iD (a unique author identifier) to help distinguish the work from that of other researchers. 

For help with submissions, please contact: submission@jorr.info 

2. MANUSCRIPT CATEGORIES AND REQUIREMENTS

Original Reports

Word limit: 3,000 words (suggested), excluding abstract and references.
Abstract: Must be structured under the sub-headings: Objective(s), Methods, Results, Conclusion
References: No limit
Figures/Tables: No limit
Description: These manuscripts present data that have not yet been published. Authors must adhere to the CONSORT statement (www.consort-statement.org) when reporting a randomized trial, including a patient flow diagram.

Original Reports should be formatted as follows:

Title Page
Abstract
Keywords
Level of Evidence
Introduction
Materials and Methods
Results
Discussion
Conclusion
References
List of Figure Legends/Titles
List of Supplementary material legends/titles (if applicable)
List of Appendix titles (if applicable)

 

Reviews

Word count: 3500 words (suggested), excluding abstract and references
Abstract: Recommended subheadings are Objective(s), Methods, Results, Conclusion
References: No limit
Figures/Tables: No limit

Description: These manuscripts present clinical or scientific topics with significant recent literature and data sources. The literature and data sources should be explored in a thorough and comprehensive manner, preferably with the assistance of a librarian or other professional trained in the proper search of the medical literature. Clearly defined inclusion and exclusion criteria for the selection of articles should be used and described in the manuscript. Methods for minimizing bias in the selection and evaluation of articles should also be employed. If you choose to address a controversial topic, these manuscripts should express both sides of the controversy. The review should be comprehensive and authoritative as reflected by a bibliography of the most significant and up to date literature on the topic. The review should emphasize the best evidence currently available.

If your review includes recommendations for different treatments or procedures, these recommendations should be based on a combination of the strength of the evidence, including the assessment of the internal and external validity of the study and the relative benefit and risk of the intervention.

Reviews should be formatted as follows:

Title Page
Abstract
Keywords
Introduction
Headings
Conclusion
References
List of Figure Legends/Titles
List of Supplementary material legends/titles (if applicable)
List of Appendix titles (if applicable)

 

Reports

Suggested Word Limit: 3,500
No Abstract
Reference Limit: Four
Figure/Table Limit: None

Description: These manuscripts are to present illustrative otopathology cases with appropriate review and discussion that have not yet been accepted to, or published in, a journal. 

Otopathology  and Rhinology  Reports should be formatted as follows: Introduction, Materials and Methods, Results, Discssion.

 Editorial

Editorial manuscripts are solicited by the editors/journal. If you wish to submit an editorial, please contact the Editorial Office at editor@jorr.info


 Rapid Communication

Word Limit: 800 words
Abstract/ References: Not Required
Figures/Tables: 1 Figure or Table
A Rapid Communication is a short article, on a topic that is rapidly evolving. This article type is intended to convey important information that may not have yet fully developed into an evidence based study, but that merits expedited dissemination.

Rapid Communications should be formatted as follows:

Keywords
Level of Evidence
Introduction
Discussion
Conclusion

 

PREPARING THE MANUSCRIPT FOR SUBMISSION

Parts of the Manuscript

Your main document must be submitted in .DOC or .DOCX format. All text components of the manuscript should be in a single file; please do not split your title page, abstract, references, etc. into separate Word files.

Figures should be uploaded as separate individual files in .EPS, .JPEG or .TIFF format.

Tables should be in editable .DOC, .DOCX or .XLS format, and can be either embedded directly in the manuscript file or uploaded separately.

Video and Appendix files should each be uploaded as an individual source file.

Title Page

  • Manuscript title
  • A short running title of 40 characters;
  • The full names of the authors and highest degrees;
  • The author's institutional affiliations where the work was conducted;
  • Funding and Conflicts of Interests.
  • A note indicating the corresponding author, including full contact details (postal codes, telephone and a valid e-mail; please note this will be published with the paper and that post-acceptance correspondence will be directed to this e-mail address)
  • Meeting information, if applicable (society name, city, state, country, and exact date the meeting was held);
  • Acknowledgments

Title. The title should be short and informative, containing major keywords related to the content. The title should not contain abbreviations.

Authorship and Acknowledgments. Contributions from individuals who do not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section. Financial and material support should also be mentioned. Thanks to anonymous reviewers are not appropriate.

Conflict of Interest Statement. Authors will be asked to provide a conflict of interest statement during the manuscript submission process.  Authors should ensure they liaise with all co-authors to confirm agreement with the final statement.

Abstract and  Keywords

Abstract. Your abstract should appear immediately after the title page and before the article main body, should be 250 words, and should be structured appropriate to your manuscript type.

Keywords. Please provide 3–5 keywords.

Main Text. As specified by the description of the exact article type.

References

References All references should be numbered consecutively in order of appearance and should be as complete as possible. In text citations should cite references in consecutive order using Arabic superscript numerals. 

Tables should be cited in ascending numeric order in the article main body.

  1. Figure Legends

Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.

Figures should be cited in ascending numeric order in the article main body. A list of figure captions/legends should be provided at the end of your main document file.

Figures

Although authors are encouraged to send the highest-quality figures possible, for peer-review purposes, a wide variety of formats, sizes, and resolutions are accepted. 

  1.       Additional Files

Appendices Appendices will be published after the references. For manuscript submissions, they should be supplied as separate files but referred to in the text.

Appendices should be cited in ascending numeric order in the article main body. A list of Appendix titles should be included at the end of your main document file.

Supporting Information

Supporting information is published online only. This should be information that is not essential to the article, but provides greater depth and background. Supporting Information should be cited in ascending numeric order in the article main body. A list of supporting information titles/legends should appear at the end of your main document file.

Note: if data, scripts, or other artefacts used to generate the analyses presented in the manuscript are available via a publicly available data repository, authors should include a reference to the location of the material within their manuscript.

Videos

Video files can be uploaded with the designation “Supporting Information for review and publication.” We can accept most standard video formats, such as .mov, .mp4, and .avi. We cannot accept links to videos sourced externally. If any patients are depicted in your video files, the appropriate consent forms should be uploaded. A list of Video titles should appear at the end of your main document, and each Video should be cited in ascending numeric order in your main body.

The recommended file size for your video is 100 MB. It is recommended that videos be no longer than 5 minutes. It is also recommended that videos have an audio component, with “voice-over” explaining the video. If there is an audio component, it must be in English. The video should be of high quality (both in content and visibility).

The use of text and/or special transition effects between the titles, subtitles and video segments is permitted. The video submitted should be the final product that will be published with the article. The Editor reserves the right to request additional video editing by the authors.

Revisions

Many papers are returned to authors for revision to address specific issues raised by the reviewers. This is standard practice to ensure the quality of material published in LIO. If revisions are recommended, authors are notified by email, and will be sent with as much feedback as possible from reviewers and the Associate Editor. Papers which have extensive revisions recommended may undergo further review once resubmitted.

Authors should submit a revised paper within the deadline listed in the decision letter. We encourage authors to revise and return their paper without unnecessary delay; however, you may request a deadline extension at any time by contacting the Editorial Office.

Once you have revised your paper, taking into consideration the reviewers’ and Editors’ comments, please prepare three documents:

1) Main Document: The final unmarked version of your revised manuscript, which will go to production in the event of acceptance. This should be in .doc or .docx format.

2) Revisions Marked Copy: An additional version of your paper with revisions indicated via the highlight function or different colored font (such as red). This should be uploaded as “Additional file for Review but NOT publication.” This should also be in .doc or .docx format.

3) Point-by-point response: A document in which you address each reviewer comment that was offered in any of the decision letters you have received. Please detail where (in the manuscript) and how you revised your paper in response to each comment. Alternately, if you do not agree or choose not to incorporate a particular reviewer comment, we would encourage you to provide an explanation, which the editors will take into account as they assess your paper. This document can be in .doc, .docx or .pdf.

 

Data Storage and Documentation

Journal encourages data sharing wherever possible, unless this is prevented by ethical, privacy, or confidentiality matters. Authors publishing in the journal are therefore encouraged to make their data, scripts, and other artefacts used to generate the analyses presented in the manuscript available via a publicly available data repository; however, this is not mandatory. If the study includes original data, at least one author must confirm that he or she had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Human Studies and Subjects

For manuscripts reporting medical studies that involve human participants, a statement identifying the ethics committee that approved the study and confirmation that the study conforms to recognized standards is required in the Methods section, for example: Declaration of Helsinki; US Federal Policy for the Protection of Human Subjects; or European Medicines Agency Guidelines for Good Clinical Practice.

Animal Studies

A statement indicating that the protocol and procedures employed were ethically reviewed and approved, as well as the name of the body giving approval, must be included in the Methods section of the manuscript. Authors are encouraged to adhere to animal research reporting standards, for example the ARRIVE reporting guidelines for reporting study design and statistical analysis; experimental procedures; experimental animals and housing and husbandry. Authors should also state whether experiments were performed in accordance with relevant institutional and national guidelines for the care and use of laboratory animals:

Clinical Trial Registration

The journal requires that clinical trials are prospectively registered in a publicly accessible database and clinical trial registration numbers should be included in all manuscripts that report their results. Authors are asked to include the name of the trial register and the clinical trial registration number at the end of the abstract. If the trial is not registered, or was registered retrospectively, the reasons for this should be explained.

Research Reporting Guidelines

Accurate and complete reporting enables readers to fully appraise research, replicate it, and use it. Authors are expected to adhere to the following research reporting standards.

Species Names

Upon its first use in the title, abstract, and text, the common name of a species should be followed by the scientific name (genus, species, and authority) in parentheses. For well-known species, however, scientific names may be omitted from article titles. If no common name exists in English, only the scientific name should be used.

Genetic Nomenclature

Sequence variants should be described in the text and tables using both DNA and protein designations whenever appropriate. Sequence variant nomenclature must follow the current HGVS guidelines.

Structural Data

For manuscripts describing structural data, atomic coordinates and the associated experimental data should be deposited in the appropriate databank (see below). Please note that the data in databanks must be released, at the latest, upon publication of the article. We trust in the cooperation of our authors to ensure that atomic coordinates and experimental data are released on time.

  • Organic and organometallic compounds: Crystallographic data should not be sent as Supporting Information, but should be deposited with the Cambridge Crystallographic Data Centre (CCDC) at ccdc.cam.ac.uk/services/structure%5Fdeposit.
  • Inorganic compounds: Fachinformationszentrum Karlsruhe (FIZ; fiz-karlsruhe.de).
  • Proteins and nucleic acids: Protein Data Bank (rcsb.org/pdb).
  • NMR spectroscopy data: BioMagResBank (bmrb.wisc.edu).

Conflict of Interest

The journal requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript.

Potential sources of conflict of interest include, but are not limited to: patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker's fees from a company. The existence of a conflict of interest does not preclude publication. If the authors have no conflict of interest to declare, they must also state this at submission. It is the responsibility of the corresponding author to review this policy with all authors and collectively to disclose with the submission ALL pertinent commercial and other relationships.

Funding

Authors should list all funding sources in the Acknowledgments section. Authors are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature: https://www.crossref.org/services/funder-registry/

Funding information is collected with your manuscript submission, and is published for all accepted articles.

Authorship

The list of authors should accurately illustrate who contributed to the work and how. All those listed as authors should qualify for authorship according to the following criteria in accordance with ICMJE standards:

  1. Have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data;
  2. Been involved in drafting the manuscript or revising it critically for important intellectual content;
  3. Given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content; and
  4. Agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section (for example, to recognize contributions from people who provided technical help, collation of data, writing assistance, acquisition of funding, or a department chairperson who provided general support). Prior to submitting the article all authors should agree on the order in which their names will be listed in the manuscript.

Additional Authorship Options: Joint first or senior authorship: In the case of joint first authorship, a footnote should be added to the author listing, e.g. ‘X and Y contributed equally to this work.’

ORCID

As part of the journal’s commitment to supporting authors at every step of the publishing process, the journal requires the submitting author (only) to provide an ORCID iD when submitting a manuscript. This takes around 2 minutes to complete.